Related Experiment Videos
The tumor suppressor protein p16INK4a
1Department of Immunology and Oncology, Centro Nacional de Biotecnología, CSIC, Madrid, Spain. mserrano@cnb.uam.es
Experimental Cell Research
|January 7, 1998
Summary
The tumor suppressor p16INK4a protein is crucial for cell-cycle control and cancer. Its inactivation in tumors and inherited mutations increase cancer risk, highlighting its role in cancer susceptibility.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The p16INK4a (inhibitor of CDK4) protein acts as a critical tumor suppressor.
- p16INK4a is a key regulator of the cell cycle, directly linking it to cancer development.
- The p16INK4a gene is frequently inactivated in various human cancers.
Purpose of the Study:
- To elucidate the role of the p16INK4a tumor suppressor in cell-cycle regulation.
- To understand the implications of p16INK4a gene inactivation in human tumors.
- To investigate the mechanisms governing p16INK4a regulation.
Main Methods:
- Analysis of p16INK4a gene status in human tumors.
- Study of cell-cycle regulatory pathways involving p16INK4a and Rb.
- Characterization of molecular mechanisms controlling p16INK4a expression.
Main Results:
- Frequent inactivation of the p16INK4a gene observed in human tumors.
- Inheritance of mutant p16INK4a alleles confers susceptibility to multiple cancer types.
- p16INK4a functions within a pathway converging on the Rb tumor suppressor.
Conclusions:
- p16INK4a is a pivotal tumor suppressor with a direct role in cell-cycle control.
- Alterations in p16INK4a are significant factors in cancer development and susceptibility.
- Further research into p16INK4a regulatory mechanisms is essential for understanding cancer biology.